Frozen fresh blood plasma preserves the functionality of native human α2-macroglobulin

Soraia R Mendes1, F Xavier Gomis-Rüth2, Theodoros Goulas3

  • 1Proteolysis Lab, Molecular Biology Institute of Barcelona (CSIC), Barcelona Science Park, c/Baldiri Reixac 15-21, 08028, Barcelona, Catalonia, Spain.

Scientific Reports
|March 21, 2023
PubMed

Insights

Human α2-macroglobulin (hα2M) maintains its function after plasma freezing. Protective plasma components ensure hα2M remains competent, even after thawing frozen samples for research.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Proteomics

Background:

  • Human α2-macroglobulin (hα2M) is a crucial proteinase inhibitor.
  • hα2M undergoes conformational changes upon protease binding, trapping the enzyme.
  • Concerns exist regarding the stability and functional competence of hα2M purified from frozen plasma.

Purpose of the Study:

  • To investigate the impact of freezing and thawing on the biochemical and biophysical properties of hα2M.
  • To determine if plasma-derived hα2M from frozen sources retains functional competence compared to fresh plasma sources.

Main Methods:

  • Electrophoresis (native and SDS-PAGE)
  • Chromatography (affinity and ion-exchange)
  • Multi-angle laser light scattering (MALLS) with size-exclusion chromatography (SEC)
  • Free cysteine quantification
  • Peptidase inhibition assays

Main Results:

  • No significant differences were observed in molecular or functional properties between hα2M purified from fresh and frozen-thawed plasma.
  • Protective components within plasma maintain the native conformation and activity of hα2M during freezing and thawing.
  • hα2M remains functionally competent despite storage in frozen plasma.

Conclusions:

  • Freezing and thawing of plasma does not compromise the functional integrity of human α2-macroglobulin.
  • Plasma-derived hα2M is stable and functionally competent for biochemical studies, regardless of whether it originates from fresh or frozen sources.
  • This finding supports the continued use of frozen plasma for hα2M research.